Memphasys Limited (MEM.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -4.44 Million AUD | -30.55% |
| 2023 | -3.4 Million AUD | -63.43% |
| 2022 | -2.08 Million AUD | -40.06% |
| 2021 | -1.48 Million AUD | -31.09% |
| 2020 | -1.13 Million AUD | -8.55% |
| 2019 | -1.04 Million AUD | -160.39% |
| 2018 | -401.15 Thousand AUD | 79.94% |
| 2017 | -1.99 Million AUD | 8.04% |
| 2016 | -2.17 Million AUD | 7.85% |
| 2015 | -2.36 Million AUD | 38.58% |
| 2014 | -3.84 Million AUD | -108.59% |
| 2013 | -1.84 Million AUD | 62.59% |
| 2012 | -4.92 Million AUD | 24.98% |
| 2011 | -6.56 Million AUD | -299.39% |
| 2010 | 3.29 Million AUD | 220.18% |
| 2009 | -2.73 Million AUD | 50.16% |
| 2008 | -5.49 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.3 Million AUD | 0.0% |
| 2024 FY | -4.44 Million AUD | -30.55% |
| 2024 Q4 | -2.13 Million AUD | 0.0% |
| 2023 Q2 | -1.18 Million AUD | 0.0% |
| 2023 Q4 | -2.21 Million AUD | 0.0% |
| 2023 FY | -3.4 Million AUD | -63.43% |
| 2022 Q2 | -937.86 Thousand AUD | 0.0% |
| 2022 Q4 | -1.14 Million AUD | 0.0% |
| 2022 FY | -2.08 Million AUD | -40.06% |
| 2021 Q2 | -719.46 Thousand AUD | 0.0% |
| 2021 FY | -1.48 Million AUD | -31.09% |
| 2021 Q4 | -766.96 Thousand AUD | 0.0% |
| 2020 Q4 | -386.52 Thousand AUD | 0.0% |
| 2020 Q2 | -747.35 Thousand AUD | 0.0% |
| 2020 FY | -1.13 Million AUD | -8.55% |
| 2019 Q2 | -566.68 Thousand AUD | 0.0% |
| 2019 Q4 | -477.89 Thousand AUD | 0.0% |
| 2019 FY | -1.04 Million AUD | -160.39% |
| 2018 FY | -401.15 Thousand AUD | 79.94% |
| 2018 Q2 | 33.5 Thousand AUD | 0.0% |
| 2018 Q4 | -434.66 Thousand AUD | 0.0% |
| 2017 Q2 | -835.28 Thousand AUD | 0.0% |
| 2017 FY | -1.99 Million AUD | 8.04% |
| 2016 FY | -2.17 Million AUD | 7.85% |
| 2016 Q2 | -1.08 Million AUD | 0.0% |
| 2015 Q2 | -1.09 Million AUD | 0.0% |
| 2015 FY | -2.36 Million AUD | 38.58% |
| 2014 Q1 | -460.48 Thousand AUD | 0.0% |
| 2014 FY | -3.84 Million AUD | -108.59% |
| 2014 Q4 | 277.32 Thousand AUD | 128.87% |
| 2014 Q3 | -960.53 Thousand AUD | 26.87% |
| 2014 Q2 | -1.31 Million AUD | -185.25% |
| 2013 Q3 | -460.48 Thousand AUD | 22.45% |
| 2013 FY | -1.84 Million AUD | 62.59% |
| 2013 Q4 | -460.48 Thousand AUD | 0.0% |
| 2013 Q2 | -593.82 Thousand AUD | 62.35% |
| 2013 Q1 | -1.57 Million AUD | 0.0% |
| 2012 Q2 | -1.57 Million AUD | 0.2% |
| 2012 Q3 | -1.57 Million AUD | 0.0% |
| 2012 Q4 | -1.57 Million AUD | 0.0% |
| 2012 FY | -4.92 Million AUD | 24.98% |
| 2012 Q1 | -1.58 Million AUD | 0.0% |
| 2011 FY | -6.56 Million AUD | -299.39% |
| 2011 Q1 | 822.92 Thousand AUD | 0.0% |
| 2011 Q3 | -1.58 Million AUD | 0.0% |
| 2011 Q4 | -1.58 Million AUD | 0.0% |
| 2011 Q2 | -1.58 Million AUD | -292.03% |
| 2010 Q2 | 822.92 Thousand AUD | 220.08% |
| 2010 Q3 | 822.92 Thousand AUD | 0.0% |
| 2010 Q1 | -685.33 Thousand AUD | 0.0% |
| 2010 Q4 | 822.92 Thousand AUD | 0.0% |
| 2010 FY | 3.29 Million AUD | 220.18% |
| 2009 Q1 | -1.37 Million AUD | 0.0% |
| 2009 Q4 | -685.33 Thousand AUD | 0.0% |
| 2009 FY | -2.73 Million AUD | 50.16% |
| 2009 Q3 | -685.33 Thousand AUD | 0.0% |
| 2009 Q2 | -685.33 Thousand AUD | 50.12% |
| 2008 Q3 | -1.37 Million AUD | 0.0% |
| 2008 FY | -5.49 Million AUD | 0.0% |
| 2008 Q4 | -1.37 Million AUD | 0.0% |
| 2008 Q2 | -1.37 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 17.454% |
| Biome Australia Limited | -1.67 Million AUD | -165.957% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 90.736% |
| Biotron Limited | -3.43 Million AUD | -29.259% |
| Acrux Limited | -5.8 Million AUD | 23.413% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 76.772% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 67.973% |
| BTC Health Limited | 1.05 Million AUD | 520.93% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 64.548% |
| CSL Limited | 2.64 Billion AUD | 100.168% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 89.505% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 112.465% |
| Immutep Limited | -39.89 Million AUD | 88.866% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 102.828% |
| Noxopharm Limited | -3.57 Million AUD | -24.144% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 46.079% |
| Race Oncology Limited | -13.81 Million AUD | 67.856% |
| Starpharma Holdings Limited | -8.16 Million AUD | 45.597% |
| Tissue Repair Ltd | -4.13 Million AUD | -7.344% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 163.781% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -206.084% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -84.379% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 87.853% |
| Patrys Limited | -3.53 Million AUD | -25.511% |
| Orthocell Limited | -7.18 Million AUD | 38.142% |
| Imugene Limited | -149.68 Million AUD | 97.032% |
| PYC Therapeutics Limited | -37.72 Million AUD | 88.225% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 30.335% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 54.416% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 49.211% |
| Nanollose Limited | -1.15 Million AUD | -284.074% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -170.557% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 1470.106% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 1.364% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -55.081% |
| Nyrada Inc. | -1.38 Million AUD | -220.44% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 185.243% |
| Dimerix Limited | -17.07 Million AUD | 73.985% |
| PharmAust Limited | -9.03 Million AUD | 50.821% |
| Hexima Limited | -933.87 Thousand AUD | -375.656% |
| AnteoTech Limited | -8.88 Million AUD | 49.98% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 92.427% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 74.849% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -29.258% |
| Actinogen Medical Limited | -13.04 Million AUD | 65.947% |
| Immuron Limited | -6.93 Million AUD | 35.966% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 18.934% |